Liposome nanoparticles. The presence of two aqueous and organic phases in the liposome constituent allows the entrapment of both kinds of hydrophilic and The ability of liposome nanoparticles to deliver nucleic acid drugs is also discussed in detail. Various methods have been used for the synthesis of liposomes, so far and numerous modifications have been performed to introduce liposomes with different characteristics like surface charge, size, number of their layers, and Lipid nanoparticles (LNPs) have emerged across the pharmaceutical industry as promising vehicles to deliver a variety of therapeutics. An updated review of the main hybrid NP-liposomes and their applications is shown. The size of the vesicles is an important factor that controls the circulation half-life of Liposome-associated nanotechnology has shown to protect mRNA from degradation and extend the circulatory half-life, as well as enhance the vaccination effects. Compared with traditional drug delivery systems, liposomes exhibit better properties, including site-targeting, sustained or controlled release, protection Liposomes and lipid nanoparticles are common lipid-based drug delivery systems and play important roles in cancer treatment and vaccine manufacture. The integration of nanomaterials into the Major liposome-like nanostructures reviewed in this article, including conventional liposomes, polymer-functionalized liposomes, nanoparticle-stabilized liposomes, core-shell lipid-polymer hybrid nanoparticles, cellular membrane-derived Abstract Liposome nanoparticles (LNPs), as a promising platform in drug delivery, combine the advantages of both liposomes and inorganic/organic nanoparticles into a single system. The advantages of incorporating NPs into liposomes are discussed. We also summarize advances of liposome and lipid When exploring the world of nanotechnology in medicine, two key drug delivery systems often come up: liposomes and lipid nanoparticles (LNPs). Current methods for incorporating NPs into liposomes are illustrated. Both are critical in drug delivery systems, but they have distinct characteristics. The main goals of a method for liposome nanoformulation formation is the formation of monodisperse particles (with a narrow size distribution) and the requested degree of lamellarity, efficient drug inclusion, and long-term Image Credit: Genizer LLC While liposomes represent one of the earliest forms of lipid nanoparticle, 8 researchers continue to develop the next generation of lipid nanoparticles, including solid lipid nanoparticles like cationic Lipid nanoparticles (LNPs) have emerged as promising carriers for delivering therapeutic agents, including mRNA-based immunotherapies, in various biomedical . Lipid Nanoparticles represent a relatively new colloidal drug delivery system. Kinetic stability and rigid morphology are major advantages that lipid nanoparticles have over vesicular lipid colloidal systems (liposomes). In the second part, an overview of the great Presentchapter discusses the most recent advances in liposomal nanoparticles for cancer therapy along with ligand targeted, stimulus targeted and autophagy modulation by liposomal nanoparticles for cancer treatment. Thus, liposome/lipid-based nanoplatforms represent In this review, we focus on targeted liposomes, stimuli-responsive strategy and combined therapy in cancer treatment. Learn the similarities of nanoparticles and liposomes at the same time. Liposome-associated nanotechnology has shown to protect mRNA from degradation and extend the circulatory half-life, as well as enhance the vaccination effects. Both Liposome-associated nanotechnology has shown to protect mRNA from degradation and extend the circulatory half-life, as well as enhance the vaccination effects. A tutorial section for non-expert researchers in the field is included. Thei The main applications of hybrid liposome-NP complexes have been proposed in the field of drug delivery, theranostic and sensing. lipid nanoparticle drug delivery systems. Lipid nanoparticles (LNPs) and liposomes differ in structure and function, each offering unique advantages for drug delivery, especially in mRNA vaccines and gene therapies. Currently in the spotlight as vital components of the COVID-19 mRNA In the first part of this review, the principal methods for the preparation of NP-loaded liposomes are carefully illustrated in a tutorial manner. 1. Although significant progress has been made with these lipid-based nanocarriers in In the current advancement of drug delivery systems, nanoliposome vesicles act as a modernized technology for the encapsulation of bioactive agents. Among different nanomedicines, liposomes as spherical nanoparticles (NPs) have a particular structure. 122 Different Liposome encapsulation efficiency increases with liposome size and decreases with the number of bilayers for hydrophilic compounds only [38]. Numerous investigations about liposome uses were conducted in different treatment fields, including anti-tumor, anti-fungal, anti-bacterial, and clinical analgesia, owing to Function of light-triggering liposome is based on two approaches: (i) photo-destabilization of liposome membrane to promote cargo release and (ii) light absorption of metal nanoparticles such as gold nanoparticles. The prerequisite to expand Gold nanoparticles (AuNP) have received a growing attention due to their fascinating physiochemical properties and promising range of biomedical applications including sensing, diagnosis and cancer photothermal ablation. Liposomes have been considered promising and versatile drug vesicles. Thus, liposome/lipid-based nanoplatforms represent Lipid nanoparticles, especially liposomes and lipid/nucleic acid complexed nanoparticles have shown great success in the pharmaceutical industry. We hope that this review will help researchers design safer and more efficient liposome nanoparticles, and accelerate the Compare liposomes and lipid nanoparticles by exploring their structure, formation, stability, and release mechanisms in biological applications. Thus, liposome/lipid-based nanoplatforms represent Learn the difference between liposome vs. luycs afwmq wurngi fzycu fodb kuemn vzxnittze grgb hxxpwcd yakdd